Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Down syndrome mouse models have an abnormal enteric nervous system
Ellen M. Schill, Christina M. Wright, Alisha Jamil, Jonathan M. LaCombe, Randall J. Roper, Robert O. Heuckeroth
Ellen M. Schill, Christina M. Wright, Alisha Jamil, Jonathan M. LaCombe, Randall J. Roper, Robert O. Heuckeroth
View: Text | PDF
Research Article Development Gastroenterology

Down syndrome mouse models have an abnormal enteric nervous system

  • Text
  • PDF
Abstract

Children with trisomy 21 (Down syndrome [DS]) have a 130-fold increased incidence of Hirschsprung disease (HSCR), a developmental defect in which the enteric nervous system (ENS) is missing from the distal bowel (i.e., distal bowel is aganglionic). Treatment for HSCR is surgical resection of aganglionic bowel, but many children have bowel problems after surgery. Postsurgical problems, such as enterocolitis and soiling, are especially common in children with DS. To determine how trisomy 21 affects ENS development, we evaluated the ENS in 2 DS mouse models, Ts65Dn and Tc1. These mice are trisomic for many chromosome 21 homologous genes, including Dscam and Dyrk1a, which are hypothesized to contribute to HSCR risk. Ts65Dn and Tc1 mice have normal ENS precursor migration at E12.5 and almost normal myenteric plexus structure as adults. However, Ts65Dn and Tc1 mice have markedly reduced submucosal plexus neuron density throughout the bowel. Surprisingly, the submucosal neuron defect in Ts65Dn mice is not due to excess Dscam or Dyrk1a, since normalizing copy number for these genes does not rescue the defect. These findings suggest the possibility that the high frequency of bowel problems in children with DS and HSCR may occur because of additional unrecognized problems with ENS structure.

Authors

Ellen M. Schill, Christina M. Wright, Alisha Jamil, Jonathan M. LaCombe, Randall J. Roper, Robert O. Heuckeroth

×

Figure 9

Normalizing Dscam or Dyrk1a gene copy number in Ts65Dn mice does not correct the submucosal plexus hypoganglionosis.

Options: View larger image (or click on image) Download as PowerPoint
Normalizing Dscam or Dyrk1a gene copy number in Ts65Dn mice does not cor...
(A) Map of Ts65Dn and Tc1 trisomic regions. (B–E) Submucosal plexus of adult Euploid, Dscam+/+; Ts65Dn, Dscam+/+/+; Euploid, Dscam+/–; and Ts65Dn, Dscam+/+/–; and (F–I) Euploid, Dyrk1a+/+; Ts65Dn, Dyrk1a +/+/+; Euploid, Dyrk1a +/–; and Ts65Dn, Dyrk1a +/+/– mice stained for HuC/D (red). (J and K) Quantification of neuron density from images, such as B–I, indicates normalizing copy number for Dscam and Dyrk1a did not prevent distal colon hypoganglionosis (P = 0.201 Euploid, Dscam+/+ versus Ts65Dn, Dscam+/+/– and P = 0.884 Ts65Dn, Dscam+/+/+ versus Ts65Dn, Dscam+/+/–, ANOVA with post-hoc Tukey test; n = 9 [Euploid, Dscam+/+], n = 7 [Ts65Dn, Dscam+/+/+], n = 6 [Euploid, Dscam+/–], and n = 6 [Ts65Dn, Dscam+/+/–]) or DYRK1A (P = 0.048 Euploid, Dyrk1a+/+ versus Ts65Dn, Dyrk1a+/+/–, and P = 0.999 Ts65Dn, Dyrk1a+/+/– versus Ts65Dn, Dyrk1a+/+/+, ANOVA with post-hoc Tukey test; n = 4 [Euploid, Dyrk1a+/+], n = 3 [Ts65Dn, Dyrk1a+/+/+], n = 3 [Euploid, Dyrk1a+/–], and n = 3 [Ts65Dn, Dyrk1a+/+/–]). Scale bar: 100 μm. *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts